The new settlement reopens a path to ending Purdue’s chapter 11 case, the longest and costliest corporate bankruptcy stemming from the U.S. opioid epidemic.

Bankrupt Purdue Pharma LP and its owners have agreed to pay $7.4 billion to a group of U.S. states and other parties to settle long-running litigation over OxyContin’s role in the deadly opioid ...

Connecticut has joined a new $7.4 billion settlement agreement with OxyContin maker Purdue Pharma and the Sackler family members who own the company.

A bipartisan coalition of states has reached a $7.4 billion settlement in principle with members of the Sackler family and their former company Purdue Pharma over their role in the opioid crisis.

A former senior partner at McKinsey faces 20 years in prison on an obstruction charge related to the firm’s work with opioids manufacturers.

"Today’s guilty plea moves us forward in holding accountable not only ... participated in a August 2013 meeting with members ...

A former senior partner of a consulting firm that last month agreed to pay $650 million to resolve criminal and civil ...

Martin Elling, ex-McKinsey partner, pleads guilty to obstructing justice by destroying records related to Purdue Pharma's ...

"Today’s guilty plea moves us forward in holding accountable ... 2013 meeting with members of the Sackler family who owned Purdue Pharma and ultimately adopted McKinsey's proposal.